Atlas Trials

A Study of ARGX-110 in Patients With Nasopharyngeal Carcinoma (NPC)

Clinical trial NCT02759250 · COMPLETED

Trial details

NCT number
NCT02759250
Sponsor
argenx
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Cancer
Start date
2015-02-01
Primary completion
2018-04-25
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.